About 2-[4-[1-(4,4-dimethyl-5H-oxazol-2-yl)-1-methylethyl] phenyl]ethyl 4-methylbenzenesulfonate API

Therapeutic Category Intermediate for Bilastine

CAS Number 202189-76-2

API Technology Advanced Intermediate Synthesis

Dose Form Raw Material / Powder

Synergene's Development Status Available

Available Regulatory Filing In-House Quality Standards, ISO Certified

Key Reaction & Synthesis

Key advanced intermediate used in the synthetic route and chemical transformation for Bilastine. High purity HPLC grade specifications.

Primary intermediate building block for commercial manufacturing of Bilastine.

Inquiry & Quotation

Connect directly with our regulatory and commercial team for batch pricing, technical specifications, and DMF documentation.

Full Name *

Work Email *

Phone

+91

Country *

Company / Organization *

I'm not a robot

reCAPTCHA